1-2 of 2
Yukio Kobayashi, MDDSc
Close
Save search
Sort by
Journal Articles

Nilotinib Vs. Dasatinib in Achieving MR 4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212

Free
Itaru Matsumura, MDPhD, Shigeki Ohtake, MD PhD, Yoshiko Atsuta, MD PhD, Mio Kurata, Yosuke Minami, MDPhD, Naoto Takahashi, MD PhD, Chiaki Nakaseko, MDPhD, Noriyoshi Iriyama, MD PhD, Katsumichi Fujimaki, MD, Kazuhiko Kakihana, MD PhD, Yoji Ogasawara, Takaaki ONO, MD PhD, Masaya Okada, MD, Tetsuzo Tauchi, MD PhD, Toshihiro Miyamoto, MD PhD, Kazunori Ohnishi, MD, Emiko Sakaida, MDPhD, Shin Fujisawa, MD, Yukio Kobayashi, MDDSc, Norio Asou, MDPhD, Hitoshi Kiyoi, MD PhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-134168
Published: 2020
Journal Articles

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Free
Tomotaka Suzuki, MD, Suguru Fukuhara, MD, Junko Nomoto, PhD, Satoshi Yamashita, PhD, Akiko Miyagi Maeshima, MD PhD, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD PhD, Shinichi Makita, MD, PhD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD PhD, Hirokazu Taniguchi, MD, PhD, Toshikazu Ushijima, MD PhD, Koji Izutsu, MDPhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MDDSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 1571.
https://doi.org/10.1182/blood-2018-99-111262
Published: 2018